The miRNA world of polyomaviruses

Virology Journal

Volumn 10, Issue , 2013, Pages

  Lagatie, Ole ^a   Tritsmans, Luc ^b   Stuyver, Lieven J ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Immune evasion; microRNAs; Polyomaviruses; Virus host interaction

Indexed keywords

HOST FACTOR; MESSENGER RNA; MICRORNA; VIRUS PROTEIN;

BIOGENESIS; HOST; HUMAN; IMMUNE EVASION; NONHUMAN; PATHOGENESIS; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; PROTEIN EXPRESSION; REVIEW; VIRUS REPLICATION;

AVES; BOS; DNA VIRUSES; EQUIDAE; OTARIIDAE; POLYOMAVIRUS; PRIMATES; PROCYON; RODENTIA;

ANIMALS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; POLYOMAVIRUS; RNA, VIRAL;

EID: 84883130770     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-268     Document Type: Review

References (105)

1. Polyomaviruses. Imperiale MJ, Major EO, Fields Virology Philiadelphia, PA: Lippincott Williams & Wilkins, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, 5 2007 2263 2298
2. Structure of simian virus 40 at 3.8-A resolution. Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC, Nature 1991 354 6351 278 284 10.1038/354278a0 1659663 (Pubitemid 21896873)
3. The structure of simian virus 40 refined at 3.1 A resolution. Stehle T, Gamblin SJ, Yan Y, Harrison SC, Structure 1996 4 2 165 182 10.1016/S0969- 2126(96)00020-2 8805523 (Pubitemid 126658980)
4. Update on human polyomaviruses and cancer. Gjoerup O, Chang Y, Adv Cancer Res 2010 106 1 51 20399955
5. International Committee on Taxonomy of Viruses., Van Regenmortel MHV, International Union of Microbiological Societies, Virology Division, Virus taxonomy: classification and nomenclature of viruses: seventh report of the International Committee on Taxonomy of Viruses San Diego: Academic Press 2000
6. Neoplasms in mice inoculated with a tumor agent carried in tissue culture. Stewart SE, Eddy BE, Borgese N, J Natl Cancer Inst 1958 20 6 1223 1243 13549981
7. The vacuolating virus, S.V. 40. Sweet BH, Hilleman MR, Proc Soc Exp Biol Med 1960 105 420 427 10.3181/00379727-105-26128 13774265
8. New human papovavirus (B.K.) isolated from urine after renal transplantation. Gardner SD, Field AM, Coleman DV, Hulme B, Lancet 1971 1 7712 1253 1257 4104714
9. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH, Lancet 1971 1 7712 1257 1260 4104715
10. A cornucopia of human polyomaviruses. DeCaprio JA, Garcea RL, Nat Rev Microbiol 2013 11 4 264 276 10.1038/nrmicro2992 23474680
11. Human polyomaviruses in disease and cancer. Dalianis T, Hirsch HH, Virology 2013 437 2 63 72 10.1016/j.virol.2012.12.015 23357733
12. Genome analysis of the new human polyomaviruses. Van Ghelue M, Khan MT, Ehlers B, Moens U, Rev Med Virol 2012 22 6 354 377 10.1002/rmv.1711 22461085
13. Identification of a novel human polyomavirus in organs of the gastrointestinal tract. Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, Moens U, Sauer I, Voigt S, Schmuck R, Ehlers B, PLoS One 2013 8 3 58021 10.1371/journal.pone.0058021 23516426
14. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO, Clin Microbiol Rev 2012 25 3 471 506 10.1128/CMR.05031-11 22763635
15. Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Tavazzi E, White MK, Khalili K, Rev Med Virol 2011 22 1 18 32 21936015
16. Pathogenesis of progressive multifocal leukoencephalopathy-revisited. White MK, Khalili K, J Infect Dis 2011 203 5 578 586 10.1093/infdis/jiq097 21227915
17. Management of polyomavirus-associated nephropathy in renal transplant recipients. Kuypers DR, Nat Rev Nephrol 2012 8 7 390 402 10.1038/nrneph.2012.64 22508181
18. The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. White MK, Gordon J, Khalili K, PLoS Pathog 2013 9 3 1003206 10.1371/journal.ppat.1003206 23516356
19. The role of polyomaviruses in human disease. Jiang M, Abend JR, Johnson SF, Imperiale MJ, Virology 2009 384 2 266 273 10.1016/j.virol.2008.09.027 18995875
20. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC, PLoS Pathog 2010 6 7 1001024 10.1371/journal.ppat.1001024 20686659
21. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Knowles WA, Adv Exp Med Biol 2006 577 19 45 10.1007/0-387-32957-9-2 16626025
22. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. Trowbridge PW, Frisque RJ, J Neurovirol 1995 1 2 195 206 10.3109/13550289509113966 9222358
23. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. Abend JR, Joseph AE, Das D, Campbell-Cecen DB, Imperiale MJ, J Gen Virol 2009 90 Pt 5 1238 1245 19264611
24. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y, Proc Natl Acad Sci USA 2008 105 42 16272 16277 10.1073/pnas.0806526105 18812503
25. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, et al. EMBO J 2012 31 17 3513 3523 10.1038/emboj.2012.183 22773185
26. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Lilyestrom W, Klein MG, Zhang R, Joachimiak A, Chen XS, Genes Dev 2006 20 17 2373 2382 10.1101/gad.1456306 16951253 (Pubitemid 44320386)
27. A wolf in sheep's clothing: SV40 co-opts host genome maintenance proteins to replicate viral DNA. Sowd GA, Fanning E, PLoS Pathog 2012 8 11 1002994 10.1371/journal.ppat.1002994 23144614
28. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. Welcker M, Clurman BE, J Biol Chem 2005 280 9 7654 7658 15611062 (Pubitemid 40349658)
29. Bypass of a protein barrier by a replicative DNA helicase. Yardimci H, Wang X, Loveland AB, Tappin I, Rudner DZ, Hurwitz J, van Oijen AM, Walter JC, Nature 2012 492 7428 205 209 10.1038/nature11730 23201686
30. Merkel Cell Polyomavirus Large T Antigen has Growth Promoting and Inhibitory Activities. Cheng J, Rozenblatt-Rosen O, Paulson KG, Nghiem P, Decaprio JA, J Virol 2013 81 11 6118 6126
31. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM, Cell 1990 60 1 167 176 10.1016/0092-8674(90)90726-U 2153055 (Pubitemid 20033919)
32. The third subunit of protein phosphatase 2A (PP2A), a 55-kilodalton protein which is apparently substituted for by T antigens in complexes with the 36- and 63-kilodalton PP2A subunits, bears little resemblance to T antigens. Pallas DC, Weller W, Jaspers S, Miller TB, Lane WS, Roberts TM, J Virol 1992 66 2 886 893 1370560
33. Both VP2 and VP3 are synthesized from each of the alternative spliced late 19S RNA species of simian virus 40. Good PJ, Welch RC, Barkan A, Somasekhar MB, Mertz JE, J Virol 1988 62 3 944 953 2828689 (Pubitemid 18068653)
34. The late spliced 19S and 16S RNAs of simian virus 40 can be synthesized from a common pool of transcripts. Good PJ, Welch RC, Ryu WS, Mertz JE, J Virol 1988 62 2 563 571 2826816 (Pubitemid 18064199)
35. Selective translation initiation on bicistronic simian virus 40 late mRNA. Grass DS, Manley JL, J Virol 1987 61 7 2331 2335 3035232 (Pubitemid 17088953)
36. A very late viral protein triggers the lytic release of SV40. Daniels R, Sadowicz D, Hebert DN, PLoS Pathog 2007 3 7 98 10.1371/journal.ppat.0030098 17658947 (Pubitemid 47203989)
37. The Simian virus 40 late viral protein VP4 disrupts the nuclear envelope for viral release. Giorda KM, Raghava S, Hebert DN, J Virol 2012 86 6 3180 3192 10.1128/JVI.07047-11 22238309
38. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. Khalili K, White MK, Sawa H, Nagashima K, Safak M, J Cell Physiol 2005 204 1 1 7 10.1002/jcp.20266 15573377 (Pubitemid 40776801)
39. Simian virus 40 maturation in cells harboring mutants deleted in the agnogene. Ng SC, Mertz JE, Sanden-Will S, Bina M, J Biol Chem 1985 260 2 1127 1132 2981833 (Pubitemid 15173626)
40. Cellular transformation by simian virus 40 and murine polyoma virus T antigens. Cheng J, DeCaprio JA, Fluck MM, Schaffhausen BS, Semin Cancer Biol 2009 19 4 218 228 10.1016/j.semcancer.2009.03.002 19505649
41. Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Carter JJ, Daugherty MD, Qi X, Bheda-Malge A, Wipf GC, Robinson K, Roman A, Malik HS, Galloway DA, Proc Natl Acad Sci USA 2013 110 31 12744 12749 10.1073/pnas. 1303526110 23847207
42. Identification of novel genes coding for small expressed RNAs. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T, Science 2001 294 5543 853 858 10.1126/science.1064921 11679670 (Pubitemid 33032103)
43. Virus-encoded microRNAs: an overview and a look to the future. Kincaid RP, Sullivan CS, PLoS Pathog 2012 8 12 1003018 10.1371/journal.ppat.1003018 23308061
44. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Lau NC, Lim LP, Weinstein EG, Bartel DP, Science 2001 294 5543 858 862 10.1126/science.1065062 11679671 (Pubitemid 33032104)
45. An extensive class of small RNAs in Caenorhabditis elegans. Lee RC, Ambros V, Science 2001 294 5543 862 864 10.1126/science.1065329 11679672 (Pubitemid 33032105)
46. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 2 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
47. Viral miRNAs: tools for immune evasion. Boss IW, Renne R, Curr Opin Microbiol 2010 13 4 540 545 10.1016/j.mib.2010.05.017 20580307
48. MicroRNAs, macrocontrol: regulation of miRNA processing. Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A, RNA 2010 16 6 1087 1095 10.1261/rna.1804410 20423980
49. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. Bohnsack MT, Czaplinski K, Gorlich D, RNA 2004 10 2 185 191 10.1261/rna.5167604 14730017 (Pubitemid 38129823)
50. Nuclear export of microRNA precursors. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U, Science 2004 303 5654 95 98 10.1126/science.1090599 14631048 (Pubitemid 38055779)
51. Mechanisms of gene silencing by double-stranded RNA. Meister G, Tuschl T, Nature 2004 431 7006 343 349 10.1038/nature02873 15372041 (Pubitemid 39265674)
52. Perspective: machines for RNAi. Tomari Y, Zamore PD, Genes Dev 2005 19 5 517 529 10.1101/gad.1284105 15741316 (Pubitemid 40314984)
53. Analysis of the C. elegans Argonaute family reveals that distinct Argonautes act sequentially during RNAi. Yigit E, Batista PJ, Bei Y, Pang KM, Chen CC, Tolia NH, Joshua-Tor L, Mitani S, Simard MJ, Mello CC, Cell 2006 127 4 747 757 10.1016/j.cell.2006.09.033 17110334 (Pubitemid 44716250)
54. Origins and mechanisms of miRNAs and siRNAs. Carthew RW, Sontheimer EJ, Cell 2009 136 4 642 655 10.1016/j.cell.2009.01.035 19239886
55. Comparison of siRNA-induced off-target RNA and protein effects. Aleman LM, Doench J, Sharp PA, RNA 2007 13 3 385 395 10.1261/rna.352507 17237357 (Pubitemid 46327541)
56. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Djuranovic S, Nahvi A, Green R, Science 2012 336 6078 237 240 10.1126/science.1215691 22499947
57. Argonaute2 is the catalytic engine of mammalian RNAi. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ, Science 2004 305 5689 1437 1441 10.1126/science.1102513 15284456 (Pubitemid 39167657)
58. MicroRNAs and viral infection. Sullivan CS, Ganem D, Mol Cell 2005 20 1 3 7 10.1016/j.molcel.2005.09.012 16209940 (Pubitemid 41396557)
59. miRBase: microRNA sequences, targets and gene nomenclature. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ, Nucleic Acids Res 2006 34 Database issue 140 D144 16381832
60. miRBase: tools for microRNA genomics. Griffiths-Jones S, Saini HK, Van Dongen S, Enright AJ, Nucleic Acids Res 2008 36 Database issue 154 D158 17991681
61. Identification of virus-encoded microRNAs. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, et al. Science 2004 304 5671 734 736 10.1126/science.1096781 15118162 (Pubitemid 38560879)
62. Complete nucleotide sequence of polyomavirus SA12. Cantalupo P, Doering A, Sullivan CS, Pal A, Peden KW, Lewis AM, Pipas JM, J Virol 2005 79 20 13094 13104 10.1128/JVI.79.20.13094-13104.2005 16189011 (Pubitemid 41433228)
63. Evolutionarily conserved function of a viral microRNA. Seo GJ, Fink LH, O'Hara B, Atwood WJ, Sullivan CS, J Virol 2008 82 20 9823 9828 10.1128/JVI.01144-08 18684810
64. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D, Nature 2005 435 7042 682 686 10.1038/nature03576 15931223 (Pubitemid 40825513)
65. MicroRNA based immunoevasion mechanism of human polyomaviruses. Bauman Y, Mandelboim O, RNA Biol 2011 8 4 591 594 10.4161/rna.8.4.15587 21593609
66. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N, Lankry D, Gruda R, Mandelboim O, Cell Host Microbe 2011 9 2 93 102 10.1016/j.chom.2011.01.008 21320692
67. Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Sullivan CS, Sung CK, Pack CD, Grundhoff A, Lukacher AE, Benjamin TL, Ganem D, Virology 2009 387 1 157 167 10.1016/j.virol.2009.02.017 19272626
68. Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. Lee S, Paulson KG, Murchison EP, Afanasiev OK, Alkan C, Leonard JH, Byrd DR, Hannon GJ, Nghiem P, J Clin Virol 2011 52 3 272 275 10.1016/j.jcv.2011.08.012 21907614
69. Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Seo GJ, Chen CJ, Sullivan CS, Virology 2009 383 2 183 187 10.1016/j.virol.2008.11.001 19046593
70. Genomic characterization of a novel virus found in papillomatous lesions from a southern brown bandicoot (Isoodon obesulus) in Western Australia. Bennett MD, Woolford L, Stevens H, Van Ranst M, Oldfield T, Slaven M, O'Hara AJ, Warren KS, Nicholls PK, Virology 2008 376 1 173 182 10.1016/j.virol.2008.03.014 18440042
71. A novel virus detected in papillomas and carcinomas of the endangered western barred bandicoot (Perameles bougainville) exhibits genomic features of both the Papillomaviridae and Polyomaviridae. Woolford L, Rector A, Van Ranst M, Ducki A, Bennett MD, Nicholls PK, Warren KS, Swan RA, Wilcox GE, O'Hara AJ, J Virol 2007 81 24 13280 13290 10.1128/JVI.01662-07 17898069 (Pubitemid 350252962)
72. Insights into Polyomaviridae microRNA function derived from study of the bandicoot papillomatosis carcinomatosis viruses. Chen CJ, Kincaid RP, Seo GJ, Bennett MD, Sullivan CS, J Virol 2011 85 9 4487 4500 10.1128/JVI.02557-10 21345962
73. Divergent microRNA Targetomes of Closely-related Circulating Strains of a Polyomavirus. Chen CJ, Cox JE, Kincaid RP, Martinez A, Sullivan CS, J Virol 2013 in press
74. Efficiency of processing of viral RNA during the early and late phases of productive infection by polyoma virus. Acheson NH, J Virol 1981 37 2 628 635 6261010 (Pubitemid 11188791)
75. Polyomavirus late pre-mRNA processing: DNA replication-associated changes in leader exon multiplicity suggest a role for leader-to-leader splicing in the early-late switch. Hyde-DeRuyscher RP, Carmichael GG, J Virol 1990 64 12 5823 5832 2173769
76. Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing. Hyde-DeRuyscher R, Carmichael GG, Proc Natl Acad Sci USA 1988 85 23 8993 8997 10.1073/pnas.85.23.8993 2848251 (Pubitemid 19001831)
77. Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. Liu Z, Batt DB, Carmichael GG, Proc Natl Acad Sci USA 1994 91 10 4258 4262 10.1073/pnas.91.10.4258 8183899 (Pubitemid 24143412)
78. miRNA regulation of BK polyomavirus replication during early infection. Broekema NM, Imperiale MJ, Proc Natl Acad Sci USA 2013 110 20 8200 8205 10.1073/pnas.1301907110 23630296
79. Viral miRNAs and immune evasion. Boss IW, Renne R, Biochimica et biophysica acta 2011 1809 11-12 708 714 21757042
80. Roles of the NKG2D immunoreceptor and its ligands. Raulet DH, Nat Rev Immunol 2003 3 10 781 790 10.1038/nri1199 14523385 (Pubitemid 37328656)
81. Regulation of immune cell function and differentiation by the NKG2D receptor. Zafirova B, Wensveen FM, Gulin M, Polic B, CMLS 2011 68 21 3519 3529 10.1007/s00018-011-0797-0 21898152
82. Regulation of ligands for the NKG2D activating receptor. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H, Annu Rev Immunol 2013 31 413 441 10.1146/annurev-immunol-032712-095951 23298206
83. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O, Cell Host Microbe 2009 5 4 376 385 10.1016/j.chom.2009.03.003 19380116
84. Host immune system gene targeting by a viral miRNA. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, et al. Science 2007 317 5836 376 381 10.1126/science.1140956 17641203 (Pubitemid 47106378)
85. Functionally orthologous viral and cellular microRNAs studied by a novel dual-fluorescent reporter system. You X, Zhang Z, Fan J, Cui Z, Zhang XE, PLoS One 2012 7 4 36157 10.1371/journal.pone.0036157 22558366
86. The DMWD protein from the myotonic dystrophy (DM1) gene region is developmentally regulated and is present most prominently in synapse-dense brain areas. Westerlaken JH, Van der Zee CE, Peters W, Wieringa B, Brain Res 2003 971 1 116 127 10.1016/S0006-8993(03)02430-2 12691844 (Pubitemid 36412070)
87. The functions of animal microRNAs. Ambros V, Nature 2004 431 7006 350 355 10.1038/nature02871 15372042 (Pubitemid 39265675)
88. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD, Zhao J, Chen LP, Xing XM, et al. Oncogene 2011 30 36 3875 3886 10.1038/onc.2011.103 21460851
89. Human papillomaviruses modulate MicroRNA 145 expression to directly control genome amplification. Gunasekharan V, Laimins LA, J Virol 2013 87 10 6037 6043 10.1128/JVI.00153-13 23468503
90. The major transcriptional transactivation domain of simian virus 40 large T antigen associates nonconcurrently with multiple components of the transcriptional preinitiation complex. Johnston SD, Yu XM, Mertz JE, J Virol 1996 70 2 1191 1202 8551580 (Pubitemid 26029041)
91. MicroRNA profiling of Sendai virus-infected A549 cells identifies miR-203 as an interferon-inducible regulator of IFIT1/ISG56. Buggele WA, Horvath CM, J Virol 2013 87 16 9260 9270 10.1128/JVI.01064-13 23785202
92. Influenza A virus infection of human respiratory cells induces primary microRNA expression. Buggele WA, Johnson KE, Horvath CM, J Biol Chem 2012 287 37 31027 31040 10.1074/jbc.M112.387670 22822053
93. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-alpha. Zhang X, Daucher M, Armistead D, Russell R, Kottilil S, PLoS One 2013 8 2 55733 10.1371/journal.pone.0055733 23418453
94. microRNA expression profiling and bioinformatic analysis of dengue virusinfected peripheral blood mononuclear cells. Qi Y, Li Y, Zhang L, Huang J, Mol Med Rep 2013 7 3 791 798 23354650
95. A viral microRNA functions as an orthologue of cellular miR-155. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, et al. Nature 2007 450 7172 1096 1099 10.1038/nature05992 18075594 (Pubitemid 350273603)
96. Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Muylkens B, Coupeau D, Dambrine G, Trapp S, Rasschaert D, Arch Virol 2010 155 11 1823 1837 10.1007/s00705-010-0777-y 20680360
97. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R, J Virol 2007 81 23 12836 12845 10.1128/JVI.01804-07 17881434 (Pubitemid 350156921)
98. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, Kgosana L, Wang X, Nair V, J Virol 2009 83 1 489 492 10.1128/JVI.01166-08 18945769
99. Cellular oncomiR orthologue in EBV oncogenesis. Babu SG, Ponia SS, Kumar D, Saxena S, Comput Biol Med 2011 41 10 891 898 10.1016/j.compbiomed.2011.07.007 21880309
100. Treatment of HCV infection by targeting microRNA. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al. N Engl J Med 2013 368 18 1685 1694 10.1056/NEJMoa1209026 23534542
101. Silencing viral microRNA as a novel antiviral therapy? Moens U, J Biomed Biotechnol 2009 2009 419539 19704916
102. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM, Proc Natl Acad Sci USA 2012 109 3 941 946 10.1073/pnas.1112263109 22215596
103. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H, Science 2010 327 5962 198 201 10.1126/science.1178178 19965718
104. MicroRNA-155 is required for effector CD8(+) T cell responses to virus infection and cancer. Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, et al. Immunity 2013 38 4 742 753 10.1016/j.immuni.2012.12.006 23601686
105. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. Lind EF, Elford AR, Ohashi PS, J Immunol 2013 190 3 1210 1216 10.4049/jimmunol.1202700 23275599